1. Short term variability in FEV, and bronchodilator responsiveness in patients with obstructive ventilatory defects;Tweeddale, P.M.; Alexander, F.; McHardy, G.J.R.;Thorax,1987
2. Independent influence of reversibility of airflow obstruction and nonspecific hyperreactivity on the long term course of lung function in chronic airflow obstruction;Postma, D.S.; De Vries, K.; Koeter, G.H.; Sluiter, H.J.;Am Rev Respir Dis,1986
3. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate;Weir, D.C.; Gove, R.I.; Robertson, A.S.; Burge, P.S.;Thorax,1990
4. Quanjer Ph (ed.). Standardised lung function testing;Bull Eur Physiopathol Respir,1983
5. and the IPPB trial group. Prognosis in chronic obstructive pulmonary disease;Anthonisen, N.R.; Wright, E.C.; Hodgkin, J.E.;Am Rev Respir Dis,1986